Cargando…
An increase of CD8(+) T cell infiltration following recurrence is a good prognosticator in HNSCC
Programmed death-ligand 1 (PD-L1) expression and CD8-positive tumor-infiltrating lymphocyte (CD8(+) TIL) infiltration are essential biomarkers for immune checkpoint inhibitor therapy. The objective of this study was to compare the expression of those biomarkers between initial and recurrent HNSCCs u...
Autores principales: | So, Yoon Kyoung, Byeon, Sun-Ju, Ku, Bo Mi, Ko, Young Hyeh, Ahn, Myung-Ju, Son, Young-Ik, Chung, Man Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674485/ https://www.ncbi.nlm.nih.gov/pubmed/33208791 http://dx.doi.org/10.1038/s41598-020-77036-8 |
Ejemplares similares
-
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma
por: Ku, Bo Mi, et al.
Publicado: (2014) -
Prognostic Significance of the Post-Treatment Neutrophil-to-Lymphocyte Ratio in Pharyngeal Cancers Treated with Concurrent Chemoradiotherapy
por: Yun, Ji Min, et al.
Publicado: (2023) -
Detection of Cancer Recurrence Using Systemic Inflammatory Markers and Machine Learning after Concurrent Chemoradiotherapy for Head and Neck Cancers
por: So, Yoon Kyoung, et al.
Publicado: (2023) -
Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk “Infiltrating” HPV(−) HNSCC
por: Xu, Ke, et al.
Publicado: (2020) -
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2021)